# The Arterial Revascularization Therapies Study Part II.

> **NCT00235170** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 607 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** drug-eluting stent

## Key facts

- **NCT ID:** NCT00235170
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2004-12
- **Final completion:** 2009-04
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2009-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235170, "The Arterial Revascularization Therapies Study Part II.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00235170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*